|
|
Home
The Word Brain
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
| Cervical Cancer |
| Single Articles |
AMEDEO Cervical Cancer is free of charge.
Impact of Perioperative Empathic Care on Postoperative Psychological Status in
Patients with Cervical Cancer.
Altern Ther Health Med. 2024 Jun 14:AT10495.
PubMed
Abstract available
Association between p16/Ki-67 dual stain cytology results prior to and 6 months
after LLETZ treatment for CIN and the follow-up regimen three years after
treatment: a retrospective cohort study.
Arch Gynecol Obstet. 2024;310:493-499.
PubMed
Abstract available
Association between body mass index and lymph node metastasis among women with
cervical cancer: a systematic review and network meta-analysis.
Arch Gynecol Obstet. 2024 Jun 10. doi: 10.1007/s00404-024-07528.
PubMed
Abstract available
Interplay of miR-542, miR-126, miR-143 and miR-26b with PI3K-Akt is a Diagnostic
Signal and Putative Regulatory Target in HPV-Positive Cervical Cancer.
Biochem Genet. 2024 Jun 7. doi: 10.1007/s10528-024-10837.
PubMed
Abstract available
Prediction of cervix cancer stage and grade from diffusion weighted imaging using
EfficientNet.
Biomed Phys Eng Express. 2024;10.
PubMed
Abstract available
Dose escalation of tolinapant (ASTX660) in combination with standard radical
chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM
clinical trial (CRAIN) in UK secondary care centres.
BMC Cancer. 2024;24:702.
PubMed
Abstract available
Development of a machine learning-based model for predicting positive margins in
high-grade squamous intraepithelial lesion (HSIL) treatment by Cold Knife
Conization(CKC): a single-center retrospective study.
BMC Womens Health. 2024;24:332.
PubMed
Abstract available
Late and unusual recurrences after minimally invasive cervical cancer surgery.
BMJ Case Rep. 2024;17:e258831.
PubMed
Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic
evaluation of an integrated home-based approach for genital multipathogen
screening in women, including female genital schistosomiasis, human
papillomavirus, Trichomonas and
BMJ Open. 2024;14:e080395.
PubMed
Abstract available
Internal validation of Automated Visual Evaluation (AVE) on smartphone images for
cervical cancer screening in a prospective study in Zambia.
Cancer Med. 2024;13:e7355.
PubMed
Abstract available
Cervical cancer-specific long non-coding RNA landscape reveals the favorable
prognosis predictive performance of an ion-channel-related signature model.
Cancer Med. 2024;13:e7389.
PubMed
Abstract available
Correction: Activation of AMPK inhibits cervical cancer growth by
hyperacetylation of H3K9 through PCAF.
Cell Commun Signal. 2024;22:327.
PubMed
PAX1 methylation as a robust predictor: developing and validating a nomogram for
assessing endocervical curettage (ECC) necessity in human
papillomavirus16/18-positive women undergoing colposcopy.
Clin Epigenetics. 2024;16:77.
PubMed
Abstract available
Prevalence and Genotype Distribution of HPV in Hangzhou, China.
Clin Lab. 2024;70.
PubMed
Abstract available
Classification of cervical lesions based on multimodal features fusion.
Comput Biol Med. 2024;177:108589.
PubMed
Abstract available
A Study to Assess the Impact of Education on the Knowledge and Attitude Toward
Cervical Cancer and HPV (Human Papillomavirus) Vaccination Among Female
Healthcare Students.
Cureus. 2024;16:e59856.
PubMed
Abstract available
Multitargeted Docking, DFT-Based Optimisation, Pharmacokinetics, and MD
Simulation Reveal 6-Oxidopamine HBr as a Multitargeted Inhibitor of Cervical
Cancer Proteins.
Curr Med Chem. 2024 Jun 13. doi: 10.2174/0109298673289824240529063416.
PubMed
Abstract available
Atypical glandular cells and predictive features of malignancy in Pap smears: A
retrospective monocentric study.
Cytopathology. 2024;35:473-480.
PubMed
Abstract available
Tall-columnar glandular cells in SurePath liquid-based cytology Pap sample:
Learning from mimics/pitfalls.
Cytopathology. 2024;35:510-514.
PubMed
Abstract available
Prevalence of non 16/18 high risk human papilloma virus as a quality metric in
gynecological cytology.
Diagn Cytopathol. 2024 Apr 23. doi: 10.1002/dc.25327.
PubMed
Abstract available
Letter to "Correlation of immediate prevalence of cervical squamous cell
precancers and cancers with HPV genotype and age in women with LSIL cytology".
Diagn Cytopathol. 2024;52:400.
PubMed
Letter to "Correlation of immediate prevalence of cervical squamous cell
precancers and cancers with HPV genotype and age in women with LSIL cytology".
Diagn Cytopathol. 2024;52:401.
PubMed
Clinical vaginal-microecology testing using double-fluorescence staining in
patients with high-risk human papillomavirus infection.
Diagn Microbiol Infect Dis. 2024;109:116342.
PubMed
Abstract available
Novel Hsp90-Targeting PROTACs: Enhanced synergy with cisplatin in combination
therapy of cervical cancer.
Eur J Med Chem. 2024;275:116572.
PubMed
Abstract available
Amine-functionalized mesoporous silica nanoparticles decorated by silver
nanoparticles for delivery of doxorubicin in breast and cervical cancer cells.
Eur J Pharm Biopharm. 2024 Jun 5:114349. doi: 10.1016/j.ejpb.2024.114349.
PubMed
Abstract available
Perineural invasion: An independent risk factor for cervical cancer prognosis and
a possible pathway for a future targeted treatment?
Eur J Surg Oncol. 2024;50:108449.
PubMed
What is the role of circRNAs in the pathogenesis of cervical cancer? A systematic
literature review.
Front Genet. 2024;15:1287869.
PubMed
Abstract available
Integrated bioinformatics combined with machine learning to analyze shared
biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.
Front Immunol. 2024;15:1351908.
PubMed
Abstract available
Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell
antitumor function in a human cervical tumor xenograft model.
Front Immunol. 2024;15:1362904.
PubMed
Abstract available
Effect of different treatment modalities on the prognosis of patients with stage
IIIC cervical cancer.
Front Oncol. 2024;14:1405778.
PubMed
Abstract available
Impact of the COVID-19 pandemic on cervical cancer screening participation,
abnormal cytology prevalence and screening interval in Catalonia.
Front Oncol. 2024;14:1338859.
PubMed
Abstract available
PD-1 inhibitor plus concurrent chemoradiotherapy for high-risk locally advanced
cervical cancer.
Future Oncol. 2024 Jun 3:1-12. doi: 10.1080/14796694.2024.2342241.
PubMed
Abstract available
Clinical use of the Onclarity test with extended HPV genotyping and phenotyping
in patients with suspected squamous intraepithelial lesions.
Ginekol Pol. 2024;95:328-334.
PubMed
Abstract available
Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent
cervical cancer.
Gynecol Oncol. 2024;188:22-26.
PubMed
Abstract available
Open total mesometrial resection for cervical cancer.
Gynecol Oncol Rep. 2024;54:101410.
PubMed
Abstract available
Knowledge, awareness, and correlates of HPV vaccine acceptability among male
junior high school students in Zhejiang Province, China.
Hum Vaccin Immunother. 2024;20:2357238.
PubMed
Abstract available
Exploring the prognostic significance of immunogenic cell death-related genes as
risk biomarkers in cervical cancer.
Immun Inflamm Dis. 2024;12:e1260.
PubMed
Abstract available
Turning the tide-Recommendations to increase cervical cancer screening among
women who are underscreened.
Int J Gynaecol Obstet. 2024;166 Suppl 1:3-21.
PubMed
Patterns of use of primary and first-line chemotherapy for recurrence among
patients with cervical cancer.
Int J Gynecol Cancer. 2024 Jun 8:ijgc-2023-004860. doi: 10.1136/ijgc-2023-004860
PubMed
Abstract available
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab
plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer
(SKYSCRAPER-04).
Int J Gynecol Cancer. 2024 Jun 10:ijgc-2024-005588.
PubMed
Abstract available
PD-L1 Expression and Silva Invasion Pattern in Villoglandular Adenocarcinoma of
the Uterine Cervix.
Int J Gynecol Pathol. 2024;43:397-404.
PubMed
Abstract available
The Prevalence of Epstein-Barr Virus in Normal, Premalignant, and Malignant
Uterine Cervical Samples in Iran.
Intervirology. 2024;67:64-71.
PubMed
Abstract available
A smartphone-based standalone fluorescence spectroscopy tool for cervical
precancer diagnosis in clinical conditions.
J Biophotonics. 2024;17:e202300468.
PubMed
Abstract available
Niraparib enhances antitumor immunity and contributes to the efficacy of PD-L1
blockade in cervical cancer.
J Cancer Res Clin Oncol. 2024;150:304.
PubMed
Abstract available
The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical
Carcinogenesis: A Systematic Review in the Latina Population.
J Epidemiol Glob Health. 2024;14:480-497.
PubMed
Abstract available
Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast,
Cervical, and Colorectal Cancer Screening.
J Gen Intern Med. 2024;39:1324-1331.
PubMed
Abstract available
Prevalence and prognostic value of PD-L1 expression and tumor mutational burden
in persistent, recurrent, or metastatic cervical cancer.
J Gynecol Oncol. 2024 May 23. doi: 10.3802/jgo.2024.
PubMed
Abstract available
Primary human papillomavirus testing by clinician- versus self-collection:
Awareness and acceptance among cervical cancer screening-eligible women.
J Med Screen. 2024 Jun 13:9691413241260019. doi: 10.1177/09691413241260019.
PubMed
Abstract available
A Rare Case of Typical and Unforgettable Cervical Malignant Melanoma.
J Minim Invasive Gynecol. 2024;31:472-473.
PubMed
Keratinocyte differentiation factor 1 enhances cervical cancer cell viability and
migration by activating the PI3K/AKT pathway.
J Obstet Gynaecol. 2024;44:2362420.
PubMed
Abstract available
Prediction of outcomes after chemoradiotherapy for cervical cancer by
neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
J Obstet Gynaecol. 2024;44:2361858.
PubMed
Abstract available
Multiomics sequencing and immune microenvironment characteristics define three
subtypes of small cell neuroendocrine carcinoma of the cervix.
J Pathol. 2024;263:372-385.
PubMed
Abstract available
J Racial Ethn Health Disparities
Adherence and Correlates of Cervical Cancer Screening Among East African
Immigrant Women in Washington State.
J Racial Ethn Health Disparities. 2024 Jun 7. doi: 10.1007/s40615-024-02038.
PubMed
Abstract available
Co-evolution of vaginal microbiome and cervical cancer.
J Transl Med. 2024;22:559.
PubMed
Abstract available
Do HPV 16 positive/ASC-H cervical cancer screening results predict CIN 2+ better
than other high-risk HPV subtypes?
J Turk Ger Gynecol Assoc. 2024;25:90-95.
PubMed
Abstract available
Building Capacity for Cervical Cancer Prevention in U.S.-Affiliated Pacific
Islands: The Pacific Against Cervical Cancer Project.
J Womens Health (Larchmt). 2024 Jun 12. doi: 10.1089/jwh.2024.0284.
PubMed
Abstract available
Cervical Cancer Screening Rates Among Rural and Urban Females, From 2019 to 2022.
JAMA Netw Open. 2024;7:e2417094.
PubMed
Abstract available
IRTKS contributes to the malignant progression of cervical cancer cells.
Med Oncol. 2024;41:174.
PubMed
Abstract available
Development and validation of nomograms to predict survival of primary cervical
lymphoma: A surveillance, epidemiology, and end results (SEER) database analysis.
Medicine (Baltimore). 2024;103:e38528.
PubMed
Abstract available
Understanding the HPV associated cancers: A comprehensive review.
Mol Biol Rep. 2024;51:743.
PubMed
Abstract available
Targeted nanotherapy platform mediated tumor-infiltrating CD8(+) T cell immune
function effects for collaborative anti-tumor photothermal immunotherapy for
cervical cancer.
Nanoscale Adv. 2024;6:3052-3063.
PubMed
Abstract available
Naunyn Schmiedebergs Arch Pharmacol
CircVIRMA enhances cell malignant behavior by governing the miR-452-5p/CREBRF
pathway in cervical cancer.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun 8. doi: 10.1007/s00210-024-03159.
PubMed
Abstract available
Circ_0081723 enhances cervical cancer progression and modulates CREBRF via
sponging miR-545-3p.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun 8. doi: 10.1007/s00210-024-03175.
PubMed
Abstract available
Application value of artificial intelligence algorithm-based magnetic resonance
multi-sequence imaging in staging diagnosis of cervical cancer.
Open Life Sci. 2024;19:20220733.
PubMed
Abstract available
Predicting cervical cancer risk probabilities using advanced H20 AutoML and local
interpretable model-agnostic explanation techniques.
PeerJ Comput Sci. 2024;10:e1916.
PubMed
Abstract available
Effect of 5-aminolevulinic acid photodynamic therapy versus loop electrosurgical
excision procedure for cervical intraepithelial neoplasia grade 2 treatment.
Photodiagnosis Photodyn Ther. 2024;47:104107.
PubMed
Abstract available
Long-term follow-up of photodynamic therapy of cervical intraepithelial neoplasia
grade 2 (CIN2).
Photodiagnosis Photodyn Ther. 2024;47:104219.
PubMed
Abstract available
The association between smoking and cervical human papillomavirus infection among
women from indigenous communities in western Botswana.
PLoS One. 2024;19:e0302153.
PubMed
Abstract available
Identification of exosomal circSLC26A4 as a liquid biopsy marker for cervical
cancer.
PLoS One. 2024;19:e0305050.
PubMed
Abstract available
Prevalence characteristics of cervical human papillomavirus infection in Chengdu
and Aba District, Sichuan Province, China.
PLoS One. 2024;19:e0304760.
PubMed
Abstract available
Glyoxalase 1: Emerging biomarker and therapeutic target in cervical cancer
progression.
PLoS One. 2024;19:e0299345.
PubMed
Abstract available
(125)I seed brachytherapy for non-central pelvic recurrence of cervical cancer
after external beam radiotherapy.
Radiat Oncol. 2024;19:70.
PubMed
Abstract available
Cervical human papillomavirus prevalence according to socioeconomic and
demographic characteristics in a large Danish screening population.
Scand J Public Health. 2024;52:502-510.
PubMed
Abstract available
Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep
Learning for the treatment of Cervical Cancer.
Sci Rep. 2024;14:13251.
PubMed
Abstract available
Cervical cancer screening and vaccination acceptability and attitudes among Arab
American women in Southeastern Michigan: a qualitative study.
Sci Rep. 2024;14:13624.
PubMed
Abstract available
PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy
resistance in cervical cancer stem cells.
Sci Rep. 2024;14:13670.
PubMed
Abstract available
Study on serum miR-182 as a marker for diagnosis and prognosis of cervical
cancer.
Technol Health Care. 2024 May 16. doi: 10.3233/THC-231681.
PubMed
Abstract available
Women's willingness for cervical cancer screening and associated factors among
women attending health services in Addis Ababa, Ethiopia.
Ther Adv Reprod Health. 2024;18:26334941241253181.
PubMed
Abstract available
Construction of a novel cancer-associated fibroblast-related signature to predict
clinical outcome and immune response in cervical cancer.
Transl Oncol. 2024;46:102001.
PubMed
Abstract available
HPV integration and cervical cancer: a failed evolutionary viral trait.
Trends Mol Med. 2024 Jun 8:S1471-4914(24)00131.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
